Ecosystem
Search Results
14 results found for " Ralf Westenfeld"
Posts (11)
- Addex Reports 2022 Half Year and Second Quarter Financial Results and Provides Corporate Update
pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its half-year
- Radioligands vs. Fluorescent Ligands: Binding Assays
The problem is their long half-life, which results in lower detection efficiency. Another common radioactive atom, 125I, with a higher specific activity, but a shorter half-life (60 days
- Nanobodies: New Dimensions in GPCR Signaling Research
Tailorable half-life: Nanobodies can extend their half-life through PEGylation or fusion to serum albumin This allows for tailoring the half-life of nanobodies to increase their therapeutic window depending
Other Pages (3)
- Ep 45 with Dr Ralf Jockers
Ep 45 with Dr Ralf Jockers Strategic Partners Dr. GPCR Podcast << Back to podcast list Dr. Ralf Jockers About Dr. Ralf Jockers Ralf Jockers studied in Cologne and received a Ph.D. in biotechnology and biochemistry from Ralf Jockers on the web Jockers Lab WGDR-3545 Pubmed Dr.
- Session V | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Authors & Affiliations "Fabian Pohl1, Florian Seufert2, Yin Kwan Chung3, Daniela Volke1, Ralf Hoffmann1
- Terms and Conditions | Dr. GPCR Ecosystem
Each party shall bear one-half of the arbitration fees and costs. 19.
